$VCYT
Veracyte Inc Stock $vcyt

$vcyt Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000138410117000030 Filed on May 03, 2017

Income Statement

Concept	2017 Q2	2017 Q1	2016 Q1
Revenue	$18.41M	$16.43M	$13.55M
YoY Change	25.42%	21.27%	20.79%
Cost Of Revenue	$6.960M	$6.297M	$6.279M
YoY Change	10.46%	0.29%	37.4%
Gross Profit	$11.45M	$10.14M	$7.271M
YoY Change	36.68%	39.39%	9.34%
Gross Profit Margin	62.19%	61.68%	53.66%
Selling, General & Admin	$14.19M	$13.36M	$13.29M
YoY Change	-1.03%	0.46%	16.41%
% of Gross Profit	123.94%	131.77%	182.84%
Research & Development	$3.603M	$4.030M	$3.461M
YoY Change	-15.56%	16.44%	24.05%
% of Gross Profit	31.48%	39.76%	47.6%
Depreciation & Amortization	$950.0K	$902.0K	$762.0K
YoY Change	1.06%	18.37%	117.71%
% of Gross Profit	8.3%	8.9%	10.48%
Operating Expenses	$17.79M	$17.39M	$16.76M
YoY Change	-4.37%	3.76%	17.99%
Operating Profit	-$6.609M	-$7.517M	-$9.751M
YoY Change	-37.02%	-22.91%	29.15%
Interest Expense	$808.0K	$800.0K	$367.0K
YoY Change	2.93%	117.98%	-507.78%
% of Operating Profit
Other Income/Expense, Net	$119.0K	$100.0K	$43.00K
YoY Change	230.56%	132.56%	43.33%
Pretax Income	-$7.300M	-$8.220M	-$10.08M
YoY Change	-35.05%	-18.45%	32.46%
Income Tax
% Of Pretax Income
Net Earnings	-$7.300M	-$8.220M	-$10.08M
YoY Change	-35.05%	-18.45%	32.46%
Net Earnings / Revenue	-39.66%	-50.02%	-74.39%
Basic Earnings Per Share
Diluted Earnings Per Share	-$215.5K	-$243.1K	-$362.3K
COMMON SHARES
Basic Shares Outstanding	33.87M shares	33.85M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q2	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$46.50M	$51.50M	$47.50M
YoY Change	19.23%	8.42%	84.11%
Cash & Equivalents	$46.46M	$51.51M	$47.46M
Short-Term Investments
Other Short-Term Assets	$2.000M	$2.200M	$1.800M
YoY Change	33.33%	22.22%	12.5%
Inventory	$3.317M	$3.443M	$3.700M
Prepaid Expenses
Receivables	$11.03M	$9.125M	$3.200M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$62.86M	$66.30M	$56.20M
YoY Change	32.62%	17.96%	66.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.09M	$10.66M	$11.30M
YoY Change	-7.72%	-5.69%	175.61%
Goodwill	$1.057M	$1.057M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$134.0K	$127.0K	$800.0K
YoY Change	-22.09%	-84.13%	300.0%
Total Long-Term Assets	$25.49M	$26.31M	$28.10M
YoY Change	-7.1%	-6.37%	31.31%
TOTAL ASSETS
Total Short-Term Assets	$62.86M	$66.30M	$56.20M
Total Long-Term Assets	$25.49M	$26.31M	$28.10M
Total Assets	$88.35M	$92.61M	$84.30M
YoY Change	18.06%	9.85%	52.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.349M	$2.611M	$4.300M
YoY Change	-13.16%	-39.28%	-37.68%
Accrued Expenses	$8.450M	$6.800M	$7.000M
YoY Change	-5.16%	-2.86%	29.63%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$10.80M	$9.411M	$11.90M
YoY Change	-8.81%	-20.92%	-15.6%
LONG-TERM LIABILITIES
Long-Term Debt	$24.97M	$24.94M	$24.50M
YoY Change	1.22%	1.81%	400.0%
Other Long-Term Liabilities	$4.300M	$4.400M	$4.600M
YoY Change	-6.52%	-4.35%	666.67%
Total Long-Term Liabilities	$24.97M	$24.94M	$29.10M
YoY Change	1.22%	-14.28%	429.09%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.80M	$9.411M	$11.90M
Total Long-Term Liabilities	$24.97M	$24.94M	$29.10M
Total Liabilities	$40.50M	$39.26M	$41.00M
YoY Change	-1.4%	-4.25%	105.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$195.6M	-$188.3M
YoY Change	15.03%
Common Stock	$243.4M	$241.7M
YoY Change	19.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$47.84M	$53.35M	$43.30M
YoY Change
Total Liabilities & Shareholders Equity	$88.35M	$92.61M	$84.30M
YoY Change	18.06%	9.85%	52.99%

Cashflow Statement

Concept	2017 Q2	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	-$7.300M	-$8.220M	-$10.08M
YoY Change	-35.05%	-18.45%	32.46%
Depreciation, Depletion And Amortization	$950.0K	$902.0K	$762.0K
YoY Change	1.06%	18.37%	117.71%
Cash From Operating Activities	-$4.910M	-$8.090M	-$8.600M
YoY Change	-36.32%	-5.93%	-3.04%
INVESTING ACTIVITIES
Capital Expenditures	-$110.0K	$615.0K	$2.855M
YoY Change	-84.93%	-78.46%	-659.8%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$440.0K	-$120.0K
YoY Change	-100.0%	-466.67%	-271.43%
Cash From Investing Activities	-$110.0K	-$180.0K	-$2.980M
YoY Change	-81.97%	-93.96%	577.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$200.0K	$0.00
YoY Change
Debt Paid & Issued, Net		$0.00	$5.000M
YoY Change		-100.0%
Cash From Financing Activities	-20.00K	550.0K	19.95M
YoY Change	-85.71%	-97.24%	22066.67%
NET CHANGE
Cash From Operating Activities	-4.910M	-8.090M	-8.600M
Cash From Investing Activities	-110.0K	-180.0K	-2.980M
Cash From Financing Activities	-20.00K	550.0K	19.95M
Net Change In Cash	-5.040M	-7.720M	8.370M
YoY Change	-40.43%	-192.23%	-190.78%
FREE CASH FLOW
Cash From Operating Activities	-$4.910M	-$8.090M	-$8.600M
Capital Expenditures	-$110.0K	$615.0K	$2.855M
Free Cash Flow	-$4.800M	-$8.705M	-$11.46M
YoY Change	-31.23%	-24.01%	37.02%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001384101
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33870122	shares
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	VERACYTE, INC.
CY2017Q1	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017Q1	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2424000	USD
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2611000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8756000	USD
CY2017Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9125000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9110000	USD
CY2017Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6800000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	239631000	USD
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	241617000	USD
CY2016Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	91000	USD
CY2017Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	26000	USD
CY2016Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	92000	USD
CY2017Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	26000	USD
CY2016Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	267000	USD
CY2017Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	267000	USD
CY2016Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4484761	shares
CY2017Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5707064	shares
CY2016Q4	us-gaap	Assets Assets	101034000	USD
CY2017Q1	us-gaap	Assets Assets	92606000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	73627000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	66295000	USD
CY2016Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	599000	USD
CY2017Q1	us-gaap	Capital Lease Obligations CapitalLeaseObligations	528000	USD
CY2016Q1	us-gaap	Capital Leases Income Statement Interest Expense CapitalLeasesIncomeStatementInterestExpense	0	USD
CY2017Q1	us-gaap	Capital Leases Income Statement Interest Expense CapitalLeasesIncomeStatementInterestExpense	12000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39084000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47456000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59219000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51506000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	6748609	shares
CY2017Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	7993403	shares
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33762278	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33867975	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33762278	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33867975	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	34000	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	34000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10075000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8217000	USD
CY2016Q1	us-gaap	Cost Of Revenue CostOfRevenue	6279000	USD
CY2016Q1	us-gaap	Costs And Expenses CostsAndExpenses	23301000	USD
CY2017Q1	us-gaap	Costs And Expenses CostsAndExpenses	23949000	USD
CY2017Q1	us-gaap	Cost Of Revenue CostOfRevenue	6297000	USD
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	4402000	USD
CY2017Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	4373000	USD
CY2017Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	762000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	3475000	USD
CY2017Q1	us-gaap	Inventory Net InventoryNet	3443000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	41453000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	39256000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	101034000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	92606000	USD
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	762000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	902000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.36
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.24
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6120000	USD
CY2017Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3529000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14133000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13867000	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6228000	USD
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6019000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	1057000	USD
CY2017Q1	us-gaap	Goodwill Goodwill	1057000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	301000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	528000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-207000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	369000	USD
CY2016Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-115000	USD
CY2017Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-32000	USD
CY2016Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	49000	USD
CY2017Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-7000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	176000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	244000	USD
CY2016Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	120000	USD
CY2017Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	367000	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	800000	USD
CY2016Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	367000	USD
CY2017Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	800000	USD
CY2016Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	70000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11534000	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	9411000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	24918000	USD
CY2017Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	24944000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	8372000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-7713000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2975000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	19945000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	548000	USD
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	100000	USD
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2855000	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	615000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-175000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-8598000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-8086000	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10075000	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8217000	USD
CY2017Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9751000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-7517000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	19784000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2144000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2082000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2026000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2102000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	9812000	USD
CY2017Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1618000	USD
CY2016Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	628000	USD
CY2017Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	457000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2990000	USD
CY2017Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3271000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	134000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	127000	USD
CY2016Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	43000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2057000	USD
CY2017Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2101000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	200000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	24600000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2016Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2017Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	440000	USD
CY2016Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	633000	USD
CY2017Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	414000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11480000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10657000	USD
CY2016Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	66000	USD
CY2017Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2017Q1	us-gaap	Purchase Obligation PurchaseObligation	1200000	USD
CY2016Q1	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	430000	USD
CY2017Q1	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	0	USD
CY2016Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
CY2017Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	66000	USD
CY2016Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5000000	USD
CY2017Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3461000	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4030000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	120000	USD
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	120000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	603000	USD
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	603000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-180084000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-188301000	USD
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	13550000	USD
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet	16432000	USD
CY2016Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7066000	USD
CY2017Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7336000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1496000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1572000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5251832	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6549315	shares
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	59581000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	53350000	USD
CY2017Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2300000	USD
CY2017Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	USD
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27817993	shares
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33823889	shares
CY2016Q1	vcyt	Capital Expenditures Incurred But Not Yet Paid Net CapitalExpendituresIncurredButNotYetPaidNet	423000	USD
CY2017Q1	vcyt	Capital Expenditures Incurred But Not Yet Paid Net CapitalExpendituresIncurredButNotYetPaidNet	0	USD
CY2016Q1	vcyt	Debt Instrument End Of Term Payment Interest Amount DebtInstrumentEndOfTermPaymentInterestAmount	156000	USD
CY2017Q1	vcyt	Debt Instrument End Of Term Payment Interest Amount DebtInstrumentEndOfTermPaymentInterestAmount	0	USD
CY2016Q1	vcyt	Deferred Stock Offering Costs DeferredStockOfferingCosts	148000	USD
CY2017Q1	vcyt	Deferred Stock Offering Costs DeferredStockOfferingCosts	0	USD
CY2016Q1	vcyt	Increase Decrease In Accrued Liabilities And Deferred Rent IncreaseDecreaseInAccruedLiabilitiesAndDeferredRent	-1113000	USD
CY2017Q1	vcyt	Increase Decrease In Accrued Liabilities And Deferred Rent IncreaseDecreaseInAccruedLiabilitiesAndDeferredRent	-2323000	USD
CY2016Q1	vcyt	Interest Expenseand Prepayment Penalty InterestExpenseandPrepaymentPenalty	206000	USD
CY2017Q1	vcyt	Interest Expenseand Prepayment Penalty InterestExpenseandPrepaymentPenalty	0	USD
CY2017Q1	vcyt	Number Of Major Financial Institutions With Which Cash And Cash Equivalents Deposited NumberOfMajorFinancialInstitutionsWithWhichCashAndCashEquivalentsDeposited	1
CY2016Q1	vcyt	Payment Of End Of Term Obligation PaymentOfEndOfTermObligation	288000	USD
CY2017Q1	vcyt	Payment Of End Of Term Obligation PaymentOfEndOfTermObligation	0	USD
CY2016Q1	vcyt	Prepayment Penalty PrepaymentPenalty	50000	USD
CY2017Q1	vcyt	Prepayment Penalty PrepaymentPenalty	0	USD
CY2016Q1	vcyt	Revenue Percent RevenuePercent	1
CY2017Q1	vcyt	Revenue Percent RevenuePercent	1
CY2016Q1	vcyt	Revenue Recognized On Accrual Basis RevenueRecognizedOnAccrualBasis	5324000	USD
CY2017Q1	vcyt	Revenue Recognized On Accrual Basis RevenueRecognizedOnAccrualBasis	1294000	USD
CY2016Q1	vcyt	Revenue Recognized On Accrual Basis Percentage RevenueRecognizedOnAccrualBasisPercentage	0.61
CY2017Q1	vcyt	Revenue Recognized On Accrual Basis Percentage RevenueRecognizedOnAccrualBasisPercentage	0.92
CY2016Q1	vcyt	Revenue Recognized Received In Cash RevenueRecognizedReceivedInCash	8226000	USD
CY2017Q1	vcyt	Revenue Recognized Received In Cash RevenueRecognizedReceivedInCash	15138000	USD
CY2016Q1	vcyt	Revenue Recognized Received In Cash Percentage RevenueRecognizedReceivedInCashPercentage	0.39
CY2017Q1	vcyt	Revenue Recognized Received In Cash Percentage RevenueRecognizedReceivedInCashPercentage	0.08
CY2017Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the unaudited interim financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates include: revenue recognition; contractual allowances; the useful lives of property and equipment; the recoverability of long-lived assets; the estimation of the fair value of intangible assets; stock options; income tax uncertainties, including a valuation allowance for deferred tax assets; and contingencies. The Company bases these estimates on historical and anticipated results, trends and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenue and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and assumptions.</font></div></div>

Files In Submission

Name	View Source	Status
0001384101-17-000030-index-headers.html	Edgar Link	pending
0001384101-17-000030-index.html	Edgar Link	pending
0001384101-17-000030.txt	Edgar Link	pending
0001384101-17-000030-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vcyt-03312017xex311.htm	Edgar Link	pending
vcyt-03312017xex312.htm	Edgar Link	pending
vcyt-03312017xex321.htm	Edgar Link	pending
vcyt-03312017xex322.htm	Edgar Link	pending
vcyt-03312017xq110q.htm	Edgar Link	pending
vcyt-20170331.xml	Edgar Link	completed
vcyt-20170331.xsd	Edgar Link	pending
vcyt-20170331_cal.xml	Edgar Link	unprocessable
vcyt-20170331_def.xml	Edgar Link	unprocessable
vcyt-20170331_lab.xml	Edgar Link	unprocessable
vcyt-20170331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VCYT
Veracyte Inc Stock $vcyt

2017 Q2 Form 10-Q Financial Statement

#000138410117000030 Filed on May 03, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCYT Veracyte Inc Stock $vcyt

2017 Q2 Form 10-Q Financial Statement

#000138410117000030 Filed on May 03, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCYT
Veracyte Inc Stock $vcyt